Psychedelic Biotech Company Cybin Partners with Greenbrook to Develop Innovative Depression Treatment
Cybin CEO says agreement “serves as a major step toward establishing a national distribution network for future psychedelic therapies.”
psychedelic therapy
End of content
End of content